For enhanced results, Zepbound (tirzepatide) targets two hormones for improved weight management outcomes
The three most recent Phase 3 readouts are: TRIUMPH-4 (December 2025) showing 28.7% weight reduction at 68 weeks in obesity with knee osteoarthritis, TRANSCEND-T2D-1 (March 2026) showing A1C reductions up to 2.0% and 16.8% weight loss at 40 weeks in type 2 diabetes, and TRIUMPH-1 (May 2026) showing up to 25.0% weight reduction at 80 weeks in the pivotal obesity trial
It works by mimicking the hormone GLP-1, which targets areas of the brain that regulate appetite and food intake
So, I wouldn't call them cosmetic transformations
Were you prescribed Wegovy as an online weight-loss medication, but forgot to put it in the fridge
Low-calorie, high-protein diets, regardless of protein source, improve glucose metabolism and cardiometabolic profiles in subjects with prediabetes or type 2 diabetes and overweight or obesity